Questions or comments? Send us an email.
Leading a New Era of DiscoveryNew York, November 18—19, 2014Stern Auditorium, 1468 Madison Avenue

SINAInnovations Networking and Career Event

This networking event is designed for students and postdocs to learn about exciting career paths from industry experts. The following professionals will be situated at tables where they will be discussing their positions and fields. Students and postdocs will be able to circulate between the tables to network and explore a variety of careers involving science. Light refreshments will be served.

Date: Monday, Nov 18th
Hess Center for Science & Medicine, 2nd Floor

Attendance is limited. To RSVP: 

Sponsored by the Postdoc Executive Committee and Women in Science

Featured Experts
Haider Akmal, MDPortfolio Manager, Vaal, LLC
Field: Venture Capital and Private Equity

Dr. Haider Akmal is Portfolio Manager at Vaal, LLC, where he is responsible for asset allocation, manager selection and monitoring, and direct investments in public/private equities. Prior to joining Vaal, LLC in 2013, Dr. Akmal worked for five years as a Principal at Rho Ventures in the Venture Capital and Private Equity industry focusing on alternative energy and healthcare investments. Prior to joining Rho in 2008, he worked at McKinsey & Company where he focused on corporate strategy and business development efforts, as well as buyout transactions for private equity clients. Dr. Akmal has also founded and led his own real estate investment firm. He trained at Yale School of Medicine and received his MD degree from UCLA. He was a University of California President's Research Fellow and was inducted into the Yale Society of Distinguished Teachers.
Sara Diamond, PhDPresident and Vice-Chancellor, OCAD University
Field: Academic Administration

Dr. Sara Diamond is the President of OCAD University, Canada's "university of the imagination." Dr. Diamond holds a PhD in Computing, Information Technology and Engineering from the University of East London, a Masters in Digital Media theory from the University of Arts London, and Honours Bachelors of Arts in History and Communications from Simon Fraser University. She is an appointee of the Order of Ontario and the Royal Canadian Society of Artists and a recipient of the Queen's Diamond Jubilee Medal. While retaining OCAD University's traditional strengths in art and design, Dr. Diamond has guided the university in becoming a leader in digital media, design research and curriculum through the Digital Futures Initiative, new research in Inclusive Design, health and design, as well as in sustainable technologies and design. She is a data visualization, wearable technology and mobile media researcher, artist and designer. She developed CodeZebra, a social media software and performance and responsive fashion environment. Her artwork is held by prestigious collections such as the Museum of Modern Art, NYC and the National Gallery of Canada.
Haytham Elhawary, PhDExecutive Director, The Zahn Center
Field: Biotechnology/Engineering

Dr. Haytham Elhawary is the director of the Zahn Center for Entrepreneurship at City College of New York. His professional experience includes research in medical robotics at both Philips Electronics and Harvard Medical School. He co-founded Hibergenica, a start-up venture looking to commercialize a novel organ transplantation technology, and he performed due diligence on several medtech deals for BioEquity Capital, a secondary investment firm. He is the founder of the NY Hardware Startup Meetup and runs the NY chapter of the Startup Leadership Program, a non-profit organization which trains talented entrepreneurs. Dr. Elhawary has a PhD from Imperial College London and a Mechanical Engineering degree from University of Navarra in Spain. He also reviews theater for the blog site Theatre is Easy and loves to do improvised comedy.
Wen Fury, MD, PhDAssociate Director of Molecular Profiling, Regeneron Pharmaceuticals
Field: Pharmaceuticals

After graduating from Zhejiang Medical University (aka Zhejiang University School of Medicine) and practicing a year as a resident in internal medicine in China, Dr. Fury came to the US to pursue a PhD in molecular biology. In graduate school, Dr. Fury studied gene expression regulation and the TGF-beta signaling pathway related to wound healing under the mentorship of Dr. Francesco Ramirez at Mount Sinai School of Medicine in New York. After post-doctoral training with Dr. Harel Weinstein in Bioinformatics at Mount Sinai, she joined Regeneron Pharmaceuticals. Currently, Dr. Fury is an Associate Director of Molecular Profiling at Regeneron. Her group focuses on Next Generation Sequencing and DNA Microarray data analysis for drug target and biomarker discovery.
Michael Goldblatt, PhD, JDPresident and Chief Executive Officer, Functional Genetics, Inc.
Field: Biotechnology

Dr. Michael Goldblatt has been CEO of Functional Genetics since 2003. From 1999 to 2003, Dr. Goldblatt served as Director of Defense Sciences at the Defense Advanced Research Projects Agency (DARPA), creating new materials and mathematics technologies for national security and laying the foundation to make biological research a future historical strength of the Department of Defense. Prior to his work with the Department of Defense, Dr. Goldblatt spent 12 years with McDonald's Corporation as the Science and Technology Officer with broad global responsibilities in the areas of nutrition, product development, food safety, and corporate venture capital. Prior to McDonald's in his capacity with General Foods, he led research efforts in the use of nutrients for pharmaceutical effects and oversaw a variety of regulatory and legal issues. Dr. Goldblatt currently serves as an advisor to various government agencies, on the Boards of two journals and four emerging technology companies and maintains his legal license in Washington, DC and New York. He received his PhD and JD from University of California, Davis.
Maria Gotsch, MBAPresident and Chief Executive Officer, Partnership for NYC
Field: Finance/Investment

Ms. Maria Gotsch is the President and CEO at the Partnership Fund for New York City, which is the investment arm of the Partnership for New York City. In addition to leading the Fund's operations, Ms. Gotsch has spearheaded the creation and operation of a number of the Fund's strategic initiatives, including: FinTech Innovation Lab; New York Digital Health Accelerator; NYCSeed (seed financing for IT/digital media companies); BioAccelerate Prize NYC (proof-of-concept funding for university-based biomedical research); Arts Entrepreneurial Loan Fund (low cost loans for mid-size arts groups); and ReStart Central and Financial Recovery Fund (assistance and funding for small businesses impacted by 9/11/01). Prior to joining the Fund in 1999, Ms. Gotsch was a Managing Director at BT Wolfensohn (now part of Deutsche Bank), providing strategic and financial advice related to mergers, acquisitions, dispositions, joint ventures and the development of business strategies. Before starting with Wolfensohn, Ms. Gotsch worked at LaSalle Partners in the New York area and for Merrill Lynch Capital Markets in New York and London. Ms. Gotsch has an MBA from Harvard Business School and a BA from Wellesley College. She was also the recipient of a Fulbright Fellowship to study international relations at the Institut Universitaire de Hautes Etudes Internationales in Geneva, Switzerland.
Shannon Harding, PhDProfessor, Department of Psychology, Fairfield University
Field: Undergraduate Teaching and Research

Dr. Shannon Harding is a tenured Associate Professor in the Psychology Department at Fairfield University in Connecticut. She earned her PhD from Mount Sinai School of Medicine in 2003 in Biomedical Science with Dr. Marilyn McGinnis, examining the role of androgen receptors and the hypothalamus in the regulation of male rat reproductive behaviors. Dr. Harding runs an active research laboratory with undergraduates studying the effects of hormones during critical periods of development on adult social behaviors in rats. As part of her teaching duties, she has developed seven courses in the Psychology Department, and she co-teaches a course in the Honors program on gender identity and sexual orientation. Dr. Harding is an outspoken advocate for women in science, serving as one of the faculty advisors for the WiSTEM (Women in Science, Technology, Engineering and Math) group on campus, and Co-Directing a two-week science summer residential camp for high school girls from neighboring city of Bridgeport that encourages girls to pursue STEM-based careers. Dr. Harding was the recipient of Fairfield University's 2010 College of Arts and Sciences Distinguished Teaching Award, and is committed to service at the university level and in the community at large.
Robin Lloyd, PhDNews Director, Scientific American
Field: Media and Communication, Science Journalism

Dr. Robin Lloyd is the news editor responsible for editing and assigning stories for Scientific American's website. She also manages Scientific American's Twitter feed: @sciam. Previously, she was a senior editor for and She has additional experience in print journalism (Pasadena Star-News); wire journalism (City News Service in Los Angeles); and network online journalism ( She has a PhD in sociology from the University of California, Santa Barbara, and received a Knight Science Journalism Fellowship at the Massachusetts Institute of Technology for the 1998-1999 academic year.
Thomas Magaldi, PhDDirector of Science Alliance, New York Academy of Sciences
Field: Public Education and Outreach

Dr. Tom Magaldi is Director of Science Alliance, the professional development branch of the New York Academy of Sciences. Science Alliance offers career and professional development programing for early career scientists to supplement the training they are receiving at the bench. Dr. Magaldi received his PhD in genetics from Yale University and then conducted a postdoc at the National Cancer Institute. Dr. Magaldi has worked as a math and science tutor for underprivileged children in New Haven and as an Adjunct Professor of Biology at Montgomery College and the University of the District of Columbia. He has also worked as a virtual intern for the United States Department of State. During his internship, he collaborated with the US Embassy in Mongolia on research project to identify areas in Mongolian undergraduate and graduate STEM education that required improvement. Dr. Magaldi has also worked as an Executive Board Member for the Career Network for Science PhDs at Yale, an organization that provided networking and internship opportunities for young scientists at Yale.
Jeanne Magram, PhDSite Head, Center for Therapeutic Innovation (CTI)-NY, Pfizer, Inc
Subfield: Pharmaceuticals/Biotechnology

Dr. Jeanne Magram joined Pfizer in 2011 as Site Head of the Centers for Therapeutic Innovation (CTI)-NY. CTI is an innovative partnership between Pfizer and Academic Medical Centers with the goal to accelerate the translation of innovative discoveries into proof of mechanism in the clinic and ultimately enable the development of differentiated new medicines to treat diseases of high unmet medical need. Prior to CTI, Dr. Magram was Vice President of Immunology and Inflammation Research at Boehringer Ingelheim overseeing a department committed to drug discovery that addresses unmet medical needs in autoimmune disease and delivered candidates into clinical testing. Dr. Magram was appointed to this position in 2005 after serving as Associate Director, Cellular Immunology in the same department for three years. Prior to joining Boehringer Ingelheim in 2001, Dr. Magram was an Associate Director of GPCR Drug Discovery at OSI Pharmaceuticals after OSI?s acquisition of Cadus Pharmaceutical's Drug Discovery programs in 1999. At Cadus, she served as Group Leader for Drug Discovery. Prior to joining Cadus in 1998, Dr. Magram spent over five years at Hoffmann-La Roche focused on using model systems to understand the pathophysiology of disease and to identify new therapies. Dr. Magram completed her post-doctoral training in the laboratory of Nobel Laureate Dr. J. Michael Bishop at the University of California, San Francisco and obtained her PhD in 1987 in the laboratory of Dr. Frank Costantini in the Department of Genetics and Development at Columbia University and holds a BA (honors) in chemistry from Rutgers University.
Christina Marizzi, PhDWest Manager, Cold Spring Harbor Laboratory's DNA Learning Center (DNALC)
Field: Primary/Secondary Education and Outreach

Dr. Christine Marizzi graduated from the University of Vienna with an MS in microbiology and genetics for investigating the role of a particular protein involved in RNA splicing during replication in yeast. For her PhD thesis in genetics at the Max. F. Perutz Laboratories, University of Vienna, she worked with a unique stem-cell mutant of the plant model Arabidopsis thaliana. Since 2006 Dr. Marizzi worked on youth education programs with wienXtra and Vienna Open Lab (both based in Vienna, Austria) in Europe and the DNALC in the United States. The DNALC is the world?s first science center devoted entirely to genetics education and is an operating unit of Cold Spring Harbor Laboratory, an important center for molecular genetics research. The mission of the DNALC is to prepare students and families to thrive in the gene age. Through hands-on and virtual educational experiences for students, teachers, and the public we facilitate learning many standard molecular biology techniques and encourage scientific thinking.
Stefanie Mazlish, MBACo-Founder and Chief Financial Officer, The Solution Lab
Field: Management Consulting

Ms. Stefanie Mazlish is Co-founder of The Solution Lab, a nonprofit start-up which develops creative solutions for healthcare, pharmaceutical, and biotech companies facing strategic and operational challenges. The Solution Lab forms interdisciplinary teams of students and recent graduates with advanced degrees (PhD/MD/JD/MPH/MBA) to volunteer on management consulting projects in order to gain practical training as well as educational and networking opportunities. Ms. Mazlish has professional background in payer side healthcare, allied health higher education, and management consulting. She was a semi-finalist in the NYU Stern Social Venture Competition twice, leading start-ups focusing on renewable energy and microfinance. Ms. Mazlish earned an MBA from NYU Stern School of Business with specialization in Strategy and Finance, and a BA from The University of Chicago.
Richard R. Nelson, PhDGeorge Blumenthal Professor of International and Public Affairs, Business, and Law,
Emeritus, Columbia University
Field: Academic Research and Policy Analysis

Dr. Richard R. Nelson is an economist by formal training, but his interests and research have spanned a wide range of subjects and disciplines. Over his career he has taught at Oberlin College, Carnegie Mellon University, Yale University, and Columbia University. He now heads the program on Science, Technology, and Global Development, at the Columbia Earth Institute, and is George Blumenthal Professor of International and Public Affairs, Business, and Law, Emeritus, at Columbia University. He has served as research economist and analyst at the Rand Corporation, and at the President's Council of Economic Advisors. He was director of the Institute for Social and Policy Studies at Yale University, and has directed Columbia's Public Policy Doctoral Consortium. His central interests have been in long-run economic change. Much of his research has been directed toward understanding technological change, how economic institutions and public policies influence the evolution of technology, and how technological change in turn induces institutional and economic change more broadly.
Amy Savage, PhDDirector, Citizen Science Program, Bard College
Field: Undergraduate Teaching and Outreach

Dr. Amy Savage received her undergraduate degree at the University of Connecticut, where she studied both disease pathogenesis and assisted reproductive technologies. She received her MS in 2003 from the University of Florida, where she became interested in avian parasitology. She completed her PhD in Molecular Parasitology at Yale University, where she continued her postdoctoral training. She was heavily involved in event planning and promotion, budget management, recruitment of community partners, and staff supervision associated with Yale's McDougal Graduate Student Life program. In 2012, Dr. Savage joined the faculty of the Citizen Science program, a new science literacy program for 500 college freshmen, at Bard College, and was hired to direct the program in 2013. In her current role as director, she is responsible for curriculum development and for the recruitment, training, and management of full-time staff members, visiting Citizen Science faculty, and undergraduate laboratory assistants. She also teaches lower- and upper-division courses in the Biology program, and engages in both scientific and educational research.
Gretchen Snyder, PhDExecutive Director, Molecular Neuropharmacology; Intra-Cellular Therapies, Inc.
Field: Pharmaceuticals

Dr. Gretchen L. Snyder is currently the Executive Director of Molecular Neuropharmacology at Intra-Cellular Therapies Inc (ITI), a clinical-stage pharmaceutical company developing therapies for psychiatric diseases and neurodegenerative disorders, including schizophrenia, Parkinson's disease and Alzheimer's disease. Dr. Snyder earned her BA, magna cum laude in Psychobiology from Mount Holyoke College and her PhD in Behavioral Neuroscience from The University of Pittsburgh. Her doctoral work with Dr. Michael Zigmond helped to identify the neurochemical compensations that support behavioral function in animals sustaining sub-total dopamine loss after 6-OHDA lesions, a model of sub-clinical Parkinsonism. As a Post-Doctoral Fellow in Biogenic Amines Research Group at Abbott Laboratories (headed by Dr. John Kebabian) and later as a Research Associate and Assistant Professor at The Rockefeller University (with Nobel Laureate Dr. Paul Greengard), Dr. Snyder's work identified biochemical pathways regulating dopamine neurotransmission mediated by the dopamine and cAMP-regulated phosphoprotein, called DARPP-32. Using DARPP-32 knockout mice she identified several neuronal proteins, including glutamate and GABA receptors, as targets for regulation by dopamine, through the regulation of DARPP-32. Dr. Snyder was an Associate Professor in the Department of Neurobiology and Anatomy at Drexel University College of Medicine before joining ITI as Senior Director of Molecular Neuropharmacology in 2003. Dr. Snyder has led ITI's efforts in developing CNSProfile, the company's technology platform, and oversees target validation efforts and preclinical animal behavioral and pharmacokinetic testing for ITI's phosphodiesterase-1 (PDE1) program, which is now advancing into clinical development in partnership with Takeda Pharmaceuticals. She is author of approximately 60 peer-reviewed publications, including recent work on the biology of phosphodiesterase enzymes. She has been the recipient of numerous grants, including awards from the National Institutes of Health, the Department of Defense, NARSAD, the American Parkinson's Disease Foundation, and the Michael J Fox Foundation.
Yun Zhong, PhDBiotech Equity Research Associate, Cowen and Company
Field: Finance

Prior to joining Cowen and Company in September 2011, Dr. Zhong was a postdoctoral fellow in the department of neurology at Mount Sinai School of Medicine, studying molecular mechanisms of neurodegenerative diseases. Mr. Zhong received a BS and an MS in biophysical engineering from Osaka University in Japan and a PhD in molecular biology from The Rockefeller University.

View SINAInnovations in a larger map


SINAInnovations Event Address Recommended Parking
Icahn School of Medicine at
Mount Sinai Stern Auditorium
1468 Madison Avenue
(between 99th Sreet and 101st Street)
New York, NY 10029
CSM Underground Parking Garage
10 East 102nd Street
(between Madison Avenue and 5th Ave)
New York, NY 10029
Parking Garage Phone: 212-490-3460